Results 271 to 280 of about 212,261 (297)

Characterization of feline programmed cell death 1 and programmed cell death ligand 1

Programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) interact to regulate T cell biology. However, during infection with the human immunodeficiency virus (HIV), aberrant PD molecule expression contributes to pathological immune suppression.
openaire   +1 more source

Programmed cell death ligand-1 expression in gastroenteropancreatic neuroendocrine tumors.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2019
Gastroenteropancreatic tumors (GEPNETs) is a heterogeneous disease with variable clinical course. While promising therapeutic options exist for other adult cancers, there are no new molecular-based treatments developed for GEPNETs. One of the main targets of cancer immunotherapy is the Programmed Cell Death Ligand-1 (PD-L1) pathway.
Oktay, Esin, Yalcin, Gizem Donmez, Ekmekci, Sumeyye, Kahraman, Dudu Solakoglu, Yalcin, Abdullah, Degirmenci, Mustafa, Dirican, Ahmet, Altin, Zeynep, Ozdemir, Ozlem, Surmeli, Zeki, Diniz, Gulden, Ayhan, Semin, Bulut, Gulcan, Erdogan, Atike, Uslu, Ruchan   +14 more
openaire   +3 more sources

Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC

Journal of Thoracic Oncology, 2021
Masayuki Shirasawa, Hidehito Horinouchi, Takashi Kohno   +2 more
exaly  

Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis

Cancer Treatment Reviews, 2021
Keiichiro Mori, Benjamin Pradere, Fahad Quhal   +2 more
exaly  

Programmed cell-death-1-ligand-1 inhibitors/programmed cell-death-1-receptor antagonists

Reactions Weekly, 2020
openaire   +1 more source

Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer—Reply

JAMA Oncology, 2020
Zhijie, Wang, Zhengyi, Zhao, Jie, Wang
openaire   +2 more sources

Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis

Archives of Oral Biology, 2020
Hongzhi Quan, Liangjuan Fang
exaly  

Survival Outcomes and Safety of Programmed Cell Death/Programmed Cell Death Ligand 1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result From Phase III Trials

Cancer Control, 2022
Wenqi Qiu, Yunqing Qiu, Wei Yu
exaly  

Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer

Chest, 2017
Mónica Khunger, Adrian V Hernández, Peter J Mazzone   +2 more
exaly  

Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas

Histopathology, 2016
Dohee Kwon, Sehui Kim, Heounjeong Go
exaly